Drug Shortage Report for VISIPAQUE 320
Report ID | 217420 |
Drug Identification Number | 02145774 |
Brand name | VISIPAQUE 320 |
Common or Proper name | iodixanol injection USP |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IODIXANOL |
Strength(s) | 652MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRA-ARTERIAL INTRAVENOUS INTRA-ARTERIAL |
Packaging size | 200 mL |
ATC code | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-02-01 |
Actual start date | 2024-02-01 |
Estimated end date | 2024-02-21 |
Actual end date | 2024-02-23 |
Shortage status | Resolved |
Updated date | 2024-02-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-02-24 | English | Compare |
v7 | 2024-02-23 | French | Compare |
v6 | 2024-02-23 | English | Compare |
v5 | 2024-02-02 | English | Compare |
v4 | 2024-02-01 | French | Compare |
v3 | 2024-02-01 | English | Compare |
v2 | 2024-01-26 | French | Compare |
v1 | 2024-01-26 | English | Compare |
Showing 1 to 8 of 8